Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00006136 |
|
Recruitment Status :
Completed
First Posted : August 4, 2000
Last Update Posted : November 8, 2005
|
Sponsor:
Boston University
Information provided by:
Office of Rare Diseases (ORD)
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Primary Completion Date : | No date given |
| Study Completion Date : | No date given |